Newsletter Signup | Join Community
Combination of precision cancer medicines may represent new treatment strategy for advanced renal cell cancer.
Checkpoint inhibitor Inlyta combo heads to FDA approval-likely to become new standard treatment for renal cell cancer
First-Line Inlyta Active in Metastatic Kidney Cancer
Checkpoint Inhibitor Immunotherapy Combinations Improve Survival in Advanced Kidney Cancer – Should be the New Standard
The kinase inhibitor Cabometyx™ is effective treatment as initial and or second line treatment of advanced kidney cancer
Opdivo® approved by US FDA for treatment of advanced renal cell cancer.
Has anyone had their kidney cancer removed by laproscope? Doctor says recovery will be much quicker.